$1.52
2.01% yesterday
Nasdaq, Sep 27, 10:00 pm CET
ISIN
US68375N1037
Symbol
OPK
Sector
Industry

OPKO Health, Inc. Stock price

$1.52
-0.13 7.88% 1M
+0.45 42.06% 6M
+0.01 0.66% YTD
-0.04 2.56% 1Y
-2.20 59.14% 3Y
-0.56 26.92% 5Y
-7.12 82.41% 10Y
Nasdaq, Closing price Fri, Sep 27 2024
+0.03 2.01%
ISIN
US68375N1037
Symbol
OPK
Sector
Industry

Key metrics

Market capitalization $1.04b
Enterprise Value $1.27b
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 1.77
P/S ratio (TTM) P/S ratio 1.45
P/B ratio (TTM) P/B ratio 0.74
Revenue growth (TTM) Revenue growth -17.48%
Revenue (TTM) Revenue $716.37m
EBIT (operating result TTM) EBIT $-267.77m
Free Cash Flow (TTM) Free Cash Flow $-86.07m
Cash position $40.58m
EPS (TTM) EPS $-0.33
P/E forward negative
P/S forward 1.47
EV/Sales forward 1.80
Short interest 26.68%
Show more

Is OPKO Health, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,901 stocks worldwide.

OPKO Health, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

6 Analysts have issued a OPKO Health, Inc. forecast:

6x Buy
100%

Analyst Opinions

6 Analysts have issued a OPKO Health, Inc. forecast:

Buy
100%

Financial data from OPKO Health, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '24
+/-
%
716 716
17% 17%
100%
- Direct Costs 615 615
4% 4%
86%
101 101
55% 55%
14%
- Selling and Administrative Expenses 182 182
10% 10%
25%
- Research and Development Expense 85 85
5% 5%
12%
-166 -166
154% 154%
-23%
- Depreciation and Amortization 102 102
3% 3%
14%
EBIT (Operating Income) EBIT -268 -268
56% 56%
-37%
Net Profit -243 -243
16% 16%
-34%

In millions USD.

Don't miss a Thing! We will send you all news about OPKO Health, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

OPKO Health, Inc. Stock News

Neutral
PRNewsWire
12 days ago
Enhances Labcorp's laboratory services network and expands access to its clinical services  BURLINGTON, N.C. and MIAMI , Sept.
Neutral
GlobeNewsWire
about 2 months ago
MIAMI, Aug. 07, 2024 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) reports business highlights and financial results for the three and six months ended June 30, 2024. Highlights from the second quarter and recent weeks include the following: Enrollment underway in the MDX2001 Phase 1 trial for the treatment of solid tumor cancers.
Neutral
GlobeNewsWire
2 months ago
MIAMI, July 17, 2024 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) announces it has entered into a $250 million non-dilutive note purchase agreement with HealthCare Royalty (HCRx) secured by OPKO's profit share payments from Pfizer received pursuant to its license agreement relating to NGENLA™, a once-weekly treatment currently marketed to treat pediatric growth hormone deficiency.
More OPKO Health, Inc. News

Company Profile

OPKO Health, Inc. engages in the provision of healthcare services. It operates through the following segments: Diagnostics, Pharmaceuticals, and Corporate. The Diagnostics segment include clinical laboratory operations of BioReference, as well as point-of-care operations. The Pharmaceuticals segment includes comprises pharmaceutical operations in Chile, Mexico, Ireland, Israel, and Spain and pharmaceutical research and development operations. The company was founded in October 1991 and is headquartered in Miami, FL.

Head office United States
CEO Phillip Frost
Employees 3,930
Founded 1991
Website www.opko.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today